If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPGN.L Regulatory News (APGN)

  • There is currently no data for APGN

Form 8.3 -Applegreen plc

8 Mar 2021 15:30

RNS Number : 5063R
Syquant Capital
08 March 2021
Β 

Ap19

Β 

Β 

FORMΒ 8.3

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.3Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANEL ACT,Β 1997,Β TAKEOVERΒ RULES,Β 2013

Β 

DEALINGSΒ BYΒ PERSONSΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β ORΒ MORE

Β 

1. KEYΒ INFORMATION

Β 

Name of person dealing (Note 1)

Syquant Capital

Company dealt in

Applegreen plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

EUR 0.01 ordinary shares

Date of dealing

05/03/2021

Β 

2. INTERESTSΒ ANDΒ SHORTΒ POSITIONS

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ (followingΒ dealing)Β inΒ theΒ classΒ ofΒ relevantΒ securityΒ dealtΒ inΒ (NoteΒ 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

3,485,839 (2.88%)

(2) Derivatives (other than options)

4,327,177 (3.59%)

(3) Options and agreements to purchase/sell

Total

7,675,315 (6.47%)

Β 

(b) InterestsΒ andΒ shortΒ positionsΒ inΒ relevantΒ securitiesΒ ofΒ theΒ company,Β otherΒ thanΒ theΒ classΒ dealtΒ inΒ (NoteΒ 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

Β 

(2) Derivatives (other than options)

Β 

(3) Options and agreements to purchase/sell

Total

Ap20

Β 

Β 

1. DEALINGSΒ (NoteΒ 4)

Β 

(a) PurchasesΒ andΒ sales

Β 

Β 

Purchase/sale

Β 

Number of relevant securities

Β 

Price per unit (Note 5)

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD (equity derivatives)

CFD (equity derivatives)

Increasing a long position

Decreasing a long position

344

2

5.7 GBp

5.75 GBp

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Β 

Β 

(ii) Exercising

Β 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ transactionsΒ inΒ respectΒ ofΒ newΒ securities)Β (NoteΒ 4)

Β 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

Β 

2. OTHERΒ INFORMATION

Β 

Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

Β 

Β 

Β 

FullΒ detailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understandingΒ betweenΒ theΒ personΒ disclosing andΒ anyΒ otherΒ personΒ relatingΒ toΒ theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option referredΒ toΒ onΒ thisΒ formΒ orΒ relatingΒ toΒ theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ whichΒ anyΒ derivativeΒ referredΒ toΒ onΒ thisΒ formΒ isΒ referenced.Β IfΒ none,Β this shouldΒ beΒ stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

IsΒ aΒ SupplementalΒ FormΒ 8Β attached?Β (NoteΒ 9) Β YES/NO

Β 

Date of disclosure

08/03/2021

Contact name

Alexandre Chevtchenko

Telephone number

+33 1 42 56 92 93

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ISEEAFDPELLFEFA
Date   Source Headline
17th Apr 20202:06 pmRNSSecond Price Monitoring Extn
17th Apr 20202:00 pmRNSPrice Monitoring Extension
17th Apr 20209:05 amRNSSecond Price Monitoring Extn
17th Apr 20209:00 amRNSPrice Monitoring Extension
14th Apr 202011:06 amRNSSecond Price Monitoring Extn
14th Apr 202011:00 amRNSPrice Monitoring Extension
27th Mar 20207:00 amRNSFinal Results
24th Mar 20207:00 amRNSCOVID-19 Update
13th Feb 20207:00 amRNSNotice of Results
6th Feb 202011:02 amRNSReplacement - Holding(s) in Company
6th Feb 20209:57 amRNSHolding(s) in Company
20th Dec 20199:54 amRNSHolding(s) in Company
11th Dec 20191:25 pmRNSHolding(s) in Company
5th Nov 20197:00 amRNSEuronext Growth Dublin Notice
1st Nov 201910:30 amRNSIssue of Equity
1st Oct 20197:00 amRNSCompletion of Acquisition
20th Sep 201912:38 pmRNSInterim Dividend Timetable
20th Sep 20197:00 amRNSHalf-year Report
14th Aug 20197:00 amRNSNotice of Interim Results
7th Aug 20197:00 amRNSAcquisition of a Stake in Connecticut Operator
2nd Aug 20193:13 pmRNSHolding(s) in Company
26th Jun 20197:00 amRNSAcquisition of US forecourt operation
6th Jun 20197:00 amRNSResult of AGM
5th Jun 20197:00 amRNSAGM Statement
9th May 201911:33 amRNSHolding(s) in Company
8th May 20192:57 pmRNSHolding(s) in Company
2nd May 20196:10 pmRNSPosting of Annual Report and Notice of AGM
1st Apr 20195:17 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
28th Feb 20199:41 amRNSHolding(s) in Company
21st Feb 20191:26 pmRNSNotice of Results
21st Feb 20191:20 pmRNSHolding(s) in Company
8th Feb 20193:20 pmRNSHolding(s) in Company
29th Nov 20187:00 amRNSEnterprise Securities Market Notice
23rd Nov 20185:21 pmRNSIssue of Equity
2nd Nov 20187:00 amRNSEnterprise Securities Market Notice
1st Nov 20187:00 amRNSCompletion of Acquisition
30th Oct 201812:35 pmRNSIssue of Equity
25th Oct 201810:27 amRNSHolding(s) in Company
25th Oct 20188:00 amRNSEnterprise Securities Market Notice
25th Oct 20187:59 amRNSESM - Cancellation Notice
24th Oct 201811:00 amRNSResult of EGM
1st Oct 20184:13 pmRNSESM - Schedule One
1st Oct 20183:00 pmRNSSchedule One - Applegreen Plc
28th Sep 20188:00 amRNSESM - Lifting of Suspension Notice
28th Sep 20187:30 amRNSRestoration - Applegreen Plc
28th Sep 20187:00 amRNSEUR175m Placing & Publication of Admission Doc
21st Sep 20185:35 pmRNSHalf-year Report (Replacement)
21st Sep 20187:00 amRNSHalf-year Report
2nd Aug 20187:31 amRNSEuronext Dublin - ESM -Temporary Suspension Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.